BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15312962)

  • 1. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
    Fenoglio C; Galimberti D; Lovati C; Guidi I; Gatti A; Fogliarino S; Tiriticco M; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    Neurobiol Aging; 2004 Oct; 25(9):1169-73. PubMed ID: 15312962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
    Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
    Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.
    Galimberti D; Venturelli E; Villa C; Fenoglio C; Clerici F; Marcone A; Benussi L; Cortini F; Scalabrini D; Perini L; Restelli I; Binetti G; Cappa S; Mariani C; Bresolin N; Scarpini E
    J Alzheimers Dis; 2009; 17(1):125-33. PubMed ID: 19494437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population.
    Roh MS; Lee KY; Joo EJ; Lee N; Kim YS
    Neurosci Lett; 2007 Oct; 427(1):1-5. PubMed ID: 17928143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Berciano J
    Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
    Altamura AC; Mundo E; Cattaneo E; Pozzoli S; Dell'osso B; Gennarelli M; Vergani C; Trabattoni D; Arosio B; Clerici M
    Neuroimmunomodulation; 2010; 17(2):126-31. PubMed ID: 19923858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population.
    Rosenmann H; Meiner Z; Dresner-Pollak R; Kahana E; Aladjem Z; Grenader T; Wertman E; Abramsky O
    Neurosci Lett; 2004 Jun; 363(2):131-3. PubMed ID: 15172100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
    Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients.
    Wu YH; Fischer DF; Swaab DF
    Brain Res; 2007 Sep; 1167():13-9. PubMed ID: 17692293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
    Galimberti D; Fenoglio C; Lovati C; Venturelli E; Guidi I; Corrà B; Scalabrini D; Clerici F; Mariani C; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Dec; 27(12):1763-8. PubMed ID: 16307829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
    Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
    Segat L; Milanese M; Arosio B; Vergani C; Crovella S
    Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.
    Guidi I; Galimberti D; Venturelli E; Lovati C; Del Bo R; Fenoglio C; Gatti A; Dominici R; Galbiati S; Virgilio R; Pomati S; Comi GP; Mariani C; Forloni G; Bresolin N; Scarpini E
    Neurobiol Aging; 2005 Jun; 26(6):789-94. PubMed ID: 15718036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.